AH

Andrew Hedin

Partner @ Bessemer Venture Partners | Biotech & Healthcare VC

Greater Boston

Skills

Venture Capital
Biotechnology
Healthcare
Strategy
Management Consulting
Business Strategy
Valuation
Corporate Finance
Pharmaceutical Industry
Lifesciences
Biopharmaceuticals
Life Sciences
Financial Modeling
Start-ups
Private Equity

Education

Work Experience

  • Partner

    2015

    Focused on high growth biotech and healthcare companies Board Director @ Seismic Therapeutic, Kymera Therapeutics ($KYMR): 2018-2021, TScan Therapeutics ($TCRX): 2018-2021, Nido Biosciences, Rimsys, Peptone, Plenful, CopilotIQ Board observer and/or investor @ Curie Bio, Watershed Informatics, Collective Medical, Bright Health, Qventus, Groups, Artemis Health, AccuVein, Fractyl, Ginger/Headspace Health, Hinge Health, Inductive Bio among others

2014 - 2014

  • Operations

    2014 - 2014

    f.k.a. Health Essentials

  • Healthcare VC

    2010 - 2013

    F-Prime Capital (f.k.a. Fidelity Biosciences) invests venture capital in private therapeutics, medtech, and health IT & services companies. Executed new and follow-on investments in the US, China, and India. Invested in private biotech and health IT companies (Series A – Series D) focused on rare diseases, cancer, ophthalmology, dermatology, HR benefits and hospital equipment.

Leerink Partners LLC

2007 - 2010

  • Associate

    2007 - 2010

    Leerink Partners is a boutique investment bank and consulting firm focused exclusively on life sciences companies, including pharmaceutical, biotech, drug delivery and medical device companies. Leerink Consulting is the strategy consulting branch of the organization. Analyst: 2007 – 2009

University of Pennsylvania Department of Animal Biology, Neuroscience Laboratory

2006 - 2007

  • Neuroscience Research Assistant

    2006 - 2007

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034235/ Conducted research in Tracy Bale's neuroscience lab, which focuses on developing mouse models of stress sensitivity related to neurodevelopmental and neuropsychiatric disease.

Penn Resiliency Project

2004 - 2007

  • Psychology Research Supervisor

    2004 - 2007

    The Penn Resiliency Program (PRP), designed by Penn's research team, is a group intervention for late elementary and middle school students. The curriculum teaches cognitive-behavioral and social problem-solving skills and is based in part on cognitive-behavioral theories of depression by Aaron Beck, Albert Ellis, and Martin Seligman (Abramson, Seligman, & Teasdale, 1978; Beck, 1967, 1976; Ellis, 1962). Central to PRP is Ellis' Adversity-Consequences-Beliefs (ABC) model, the notion that our beliefs about events mediate their impact on our emotions and behavior. Through this model, students learn to detect inaccurate thoughts, to evaluate the accuracy of those thoughts, and to challenge negative beliefs by considering alternative interpretations. PRP also teaches a variety of strategies that can be used for solving problems and coping with difficult situations and emotions. Students learn techniques for assertiveness, negotiation, decision-making, social problem-solving, and relaxation. The skills taught in the program can be applied to many contexts of life, including relationships with peers and family members as well as achievement in academics or other activities.